Ehrlich Group is regularly sought out by leading high-tech, biotech and pharmaceutical companies for advice on both patent and trademark applications and prosecution. Head of the pharma and chemistry department Revital Green is noted for her expertise in the drafting and prosecution of global patent applications, while practice head Gal Ehrlich specialises in the analysis and assessment of IP portfolios. Maier Fenster is a go-to choice for drafting and prosecuting of patents in the bioengineering and medical devices sectors, areas in which head of the biotech department Hadassa Waterman is also well versed. Roy Melzer is an expert in patent prosecution for computer-related inventions.

Legal 500 Editorial commentary

Key clients

  • Stratasys Ltd.
  • Playtika LTD
  • Ramot at Tel-Aviv University Ltd.
  • LipoSphere Ltd.
  • BrainQ Technologies Ltd.
  • Kornit Digital Ltd.
  • SuperMeat the Essence of Meat Ltd.
  • Tel HaShomer Medical Research Infrastructure and Services Ltd.
  • Next Silicon Ltd
  • The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization
  • Sakura bio
  • Protalix Ltd.

Work highlights

  • Assisted Wilk Technologies International in securing patent grants and building an impressive IP portfolio.
  • Represented Stratasys by managing the IP portfolio of a world-leading manufacturer of 3D printers and 3D production systems.
  • Represented BrainQ Technologies and obtained wide IP coverage, overcoming significant challenges including US Patent Office mental steps doctrine as well as uncertainty within the fields of brain/psychiatry.

Lawyers

Leading partners: Intellectual property: filing and prosecution: patents
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.

Practice head

The lawyer(s) leading their teams.

Gal Ehrlich

Other key lawyers

Revital Green, Maier Fenster, Hadassa Waterman, Roy Melzer